Building Blocks

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

2,5-Dioxopyrrolidin-1-yl formate is a solubilized ATP analog that has been clinically developed for the treatment of cancer. This drug binds to cell membranes and causes alkylation of the acidic phospholipids in the membrane, leading to increased permeability of the membrane and release of intracellular components. 2,5-Dioxopyrrolidin-1-yl formate also interacts with lysosomes and increases their acidity, which may lead to an increase in lysosomal enzyme activity. This drug has been shown to inhibit tumor growth in a mouse model by binding to erythrocytes while it was being simultaneously administered intravenously. The chemical structures of this drug are closely related to those of phaseolus, which is known for its anticancer effects.

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

1-(4-Chlorophenyl)-1H-imidazole-2(3H)-thione is a crystalline solid that belongs to the class of imidazoles. It has been synthesized by reacting 1,2-dibromoethane with sodium methoxide in methanol. The compound was found to have a melting point of about 183°C and a molecular weight of 212.06 g/mol. This compound has been shown to interact with methanol, methoxide, and ethoxy groups. Crystallization occurs when the substance is heated to about 183°C in vacuum and then cooled slowly.

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

1-(2-Methylphenyl)propan-2-amine is a fatty acid ester that is used as an excipient in pharmaceutical dosage forms. It is used to increase the viscosity of drug solutions and suspensions, and to provide a protective coating for tablets. 1-(2-Methylphenyl)propan-2-amine is insoluble in water, but soluble in organic solvents such as alcohols and acetone. It can be prepared by reacting a primary amine with a fatty acid chloride or anhydride. The compound has been shown to have high affinity for 5HT2A receptors in vitro, which may account for its psychoactive effects.

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

The peptide is a research tool that can be used to activate certain antibodies and ion channels. It has also been shown to inhibit protein interactions. The peptide is soluble in DMSO, ethanol, and acetonitrile. It has a molecular weight of 438.4 g/mol and an empirical formula of C14H20N2O3S. The CAS number for the peptide is 436091-57-5. The chemical name of the peptide is ({2-[(5-methylisoxazol-3-yl)amino]-2-oxoethyl}thio)acetic acid.

Versatile small molecule scaffold

Versatile small molecule scaffold

JMS-17-2 is a small molecule that was shown to have a potent and selective inhibitory effect on the production of chemokines in cancer cells. It blocks the interaction between CXCL12 and its receptor, CXCR4. This interaction is important for normal bone tissue development and function, as well as for chemotaxis and metastasis of cancer cells. JMS-17-2 has been shown to prevent tumor growth in animal models by inhibiting angiogenesis, or the formation of new blood vessels to supply nutrients to tumors. The drug also inhibits tumor growth by decreasing the number of primary tumors, reducing bone lesions, and inhibiting the progression of pancreatic cancer. Clinical trials are currently being conducted to assess the efficacy of JMS-17-2 in humans with advanced solid tumors.

Versatile small molecule scaffold

Rac-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}-3-phenylpyrrolidine-2-carboxylic acid is a chiral, stereospecific, cyclic sulfate that is synthetized by the reaction of glycol with lactam. It has been found to be effective against various types of cancer cells. Rac-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}-3-phenylpyrrolidine 2 carboxylic acid is an enantiopure compound that can be used as an intermediate in the synthesis of antiinflammatory drugs such as kainic acid.

Versatile small molecule scaffold

Versatile small molecule scaffold

1-Propylpyrazole is a non-classical inhibitor of aldehyde oxidase that has been shown to have an inhibitory effect on pentane. 1-Propylpyrazole has peroxidase-like activity, which means it can bind to lipid hydroperoxides in the presence of hydrogen peroxide or peroxidase. It has also been shown to be an effective inhibitor of dehydrogenase, which is an enzyme that catalyzes the oxidation of aldehydes and ketones to carboxylic acids. This drug is not active against classical aldehyde oxidases such as alcohol dehydrogenase, but it does inhibit polyunsaturated fatty acid synthesis by binding with cytochrome P450 enzymes.

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

N-(3-Cyanophenyl)acetamide is a hydrogen-bonding molecule that has been detected in the gas phase. It has also been observed to interact with water, forming hydrogen bonding interactions and solvatochromism. The equilibrium of N-(3-cyanophenyl)acetamide can be shifted by changing the solvent conditions and pH. This molecule has three conformations when it is in the gaseous phase, including a planar conformation. In addition, N-(3-cyanophenyl)acetamide can be used as a probe for determining hydrogen bonding interactions and conformations due to its ability to form hydrogen bonds with other molecules.

Versatile small molecule scaffold

1-Chloroisoquinolin-4-ol is a phenylpyrimidine with anti-inflammatory properties. It is used in the treatment of sensitivity and mediated diseases, such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. 1-Chloroisoquinolin-4-ol inhibits the enzymatic activity of matrix metalloproteinases (MMPs), which are enzymes that break down collagen and other proteins in the body. The inhibition of MMPs by 1-chloroisoquinolin-4-ol leads to reduced inflammation and pain. This compound is also an effective inhibitor of the activities of chloride channels involved in acid secretion by cells in the stomach lining, thus inhibiting acid production. 1-Chloroisoquinolin-4-ol has been shown to have anticholesterolemic effects on liver cells due to its ability to inhibit cholesterol synthesis through inhibition of HMG CoA

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

N-(2-Phenylethyl)benzenesulfonamide is a biodegradable and aerobic catalyst that is used in the production of nitrates. It can be recycled and has a high solubility, which allows for efficient extraction from wastewater effluents. The reactor system can be operated at an aerobic or anaerobic conditions. N-(2-Phenylethyl)benzenesulfonamide is soluble in water and can be hydrolyzed by acids or bases to release ammonia gas. The process can also be sustainable due to the use of renewable energy sources such as solar, wind, tidal, or biomass power.

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

(S)-(+)-1-Bromo-2-methylbutane is a chiral molecule with two stereoisomers, the cis and trans forms. The cis form has been observed to be the more stable of the two. It is a functional theory that these two forms are not mirror images of each other because they have different conformations. (S)-(+)-1-Bromo-2-methylbutane has been used in the synthesis of a number of important molecules. The stereoisomers can be distinguished by conformational analysis and optical microscopy. (S)-(+)-1-Bromo-2-methylbutane also has an application in biotechnology for use as a precursor for hydrazones, which are important in organic chemistry and molecular biology, such as DNA sequencing.

JNJ 37822681 is a novel, potent, and selective small molecule inhibitor of the enzyme fatty acid amide hydrolase (FAAH), which is involved in the degradation of anandamide, a cannabinoid receptor ligand. The compound has been shown to be efficacious in animal models predictive of antipsychotic activity.

Versatile small molecule scaffold